Stay updated on Avelumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Solid Tumors Clinical Trial page.

Latest updates to the Avelumab in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded Adrenal cortex carcinoma and Squamous cell carcinoma of the head and neck to the study page’s condition list, aligning with ACC and HNSCC expansion cohorts.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding lapse notice and older Revision: v3.4.1; no study content or outcomes were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check77 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status with links for updates. The site revision was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Avelumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Solid Tumors Clinical Trial page.